AzTrials
AzTrials

Aerial Duel Performance in Soccer PlayersCCRP-ADNCT07458594

Combined Caffeine and Rhodiola Rosea on Aerial Duel Performance in Soccer

A study testing Caffeine and Rhodiola rosea extract in people with Aerial Duel Performance in Soccer Players, run by Beijing Sport University at 2 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will examine whether caffeine (CAF) and Rhodiola rosea (RHO) supplementation, taken alone or in combination, can improve explosive performance and soccer-specific aerial duel performance in trained male soccer players. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
What is being tested?
Caffeine and Rhodiola rosea extract
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
96 participants
Where
2 sitesChina
Study dates
30 Oct 2025to 3 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy male soccer players from the Beijing Sport University team.
  • Systematic soccer-specific training background and stable competitive level.
  • Suitable for high-intensity physical testing based on the Physical Activity Readiness Questionnaire (PAR-Q).

Who cannot join

  • History of neuromuscular or musculoskeletal system diseases.
  • Intake of caffeine (coffee/tea), other supplements, ergogenic aids, or alcohol within the last 3 months.
  • Current use of antidepressants or central nervous system stimulants.
  • Smokers.

Trial locations and contacts

2 sites in 1 country.

China2 sites
  • China Football Institute, Beijing Sport University

    Beijing, Beijing Municipality, 100084

  • Beijing Sport University

    Beijing

Other trials in China

About this study

Official title: Effects of Combined Caffeine and Rhodiola Rosea Supplementation on Aerial Duel Performance Under Fatigue in Soccer Players

This study will examine whether caffeine (CAF) and Rhodiola rosea (RHO) supplementation, taken alone or in combination, can improve explosive performance and soccer-specific aerial duel performance in trained male soccer players. In a randomized, double-blind, placebo-controlled, parallel design, participants will be assigned to placebo, RHO, CAF, or RHO+CAF for 4 weeks. Performance outcomes will be assessed before and after the intervention using countermovement jump measures (including early take-off impulse) and standardized heading tests (heading reach height, ball exit velocity, and heading duel success rate), with additional measures of neck isometric strength and perceived exertion.

Being tested
Caffeine, Rhodiola rosea extract, Placebo
Keywords
Caffeine, Rhodiola rosea, Combined Supplementation, Soccer Performance, Neuromuscular Fatigue, Countermovement Jump (CMJ), Early Impulse (Impulse₀-₂₀₀), Aerial Duel

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CaffeineDietary supplement

    Anhydrous caffeine capsules administered at a dose of 3 mg/kg body weight. Taken as a single dose 30 minutes prior to the physical performance tests.

  • Rhodiola rosea extractDietary supplement

    Standardized Rhodiola rosea extract capsules. Daily total dosage of 2.4 g (containing approx. 12 mg salidroside), taken twice daily (before breakfast and lunch) for 30 days.

  • PlaceboDietary supplement

    Appearance-matched capsules containing inert ingredients (starch or rice flour).

Study groups in NCT07458594
Study groupRoleWhat they receive
Placebo Control Group (CTR)Placebo comparatorParticipants receive empty capsules (containing starch or rice flour) identical to the active supplements for 30 days.
Receives: Dietary Supplement: Placebo
Rhodiola Rosea Group (RHO)ExperimentalDaily supplementation of 2.4g Rhodiola rosea extract (approx. 12mg salidroside) for 30 days, taken in two doses before breakfast and lunch.
Receives: Dietary Supplement: Rhodiola rosea extract
Caffeine Group (CAF)ExperimentalA single dose of 3 mg/kg body mass of anhydrous caffeine administered 30 minutes before exercise testing.
Receives: Dietary Supplement: Caffeine
Combined Rhodiola and Caffeine Group (RHO + CAF)ExperimentalCombined daily supplementation of 2.4g Rhodiola rosea for 30 days and a single 3 mg/kg dose of caffeine before testing.
Receives: Dietary Supplement: Caffeine; Dietary Supplement: Rhodiola rosea extract

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Early takeoff impulse (Impulse₀-₂₀₀)

    Calculated as the integration of vertical force over the first 200 ms of the countermovement jump (CMJ) takeoff phase, relative to body mass (N·s·kg-¹). This measures the capacity for rapid force production.

    Measured: Baseline (Day 0) and Post-intervention (Day 30), measured under both non-fatigued and fatigued conditions.

Secondary outcomes (5)
  1. Heading contact height

    Participants perform a header and touch a football suspended on a vertical jump tester with their forehead. The highest touch height from three trials is recorded to reflect aerial reach capacity.

    Measured: Baseline (Pre-test) and 4 weeks (Post-test), including measurements under both non-fatigued and fatigued conditions at each time point.

  2. Heading Ball Velocity

    The maximum velocity of the ball after heading is measured using a speed device. A ball machine is used to ensure consistent delivery direction and speed. This measures momentum transfer efficiency and technical execution.

    Measured: Baseline (Pre-test) and 4 weeks (Post-test), including measurements under both non-fatigued and fatigued conditions at each time point.

  3. Aerial Duel Success Rate

    Calculated as the percentage of successful duels out of a fixed number of trials in a standardized head-to-head setting. Success is defined as effectively contacting the ball first and directing it toward a target area.

    Measured: Baseline (Pre-test) and 4 weeks (Post-test), including measurements under both non-fatigued and fatigued conditions at each time point.

  4. Neck Isometric Strength

    Maximum isometric force measured in neck flexion and extension using a handheld dynamometer. Values are normalized to body mass ($N \cdot kg^{-1}$) to assess the stability of the head-trunk system.

    Measured: Baseline (Pre-test) and 4 weeks (Post-test).

  5. Rate of Perceived Exertion (RPE)

    Subjective effort level reported by participants on a scale of 1 to 10 (1 = nearly no effort, 10 = extreme effort) immediately following the fatigue protocol and post-fatigue tests.

    Measured: Immediately after the fatigue-induction protocol and post-fatigue testing at Baseline and 4 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Mar 2026
  2. Study start30 Oct 2025
  3. Primary completion27 Dec 2025
  4. Study completion3 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a 4-week, randomized, double-blind, placebo-controlled, parallel-group trial with four arms (placebo, Rhodiola rosea, caffeine, and Rhodiola rosea plus caffeine; n=24 per arm). Participants complete identical pre- and post-intervention testing sessions. Rhodiola rosea is administered daily throughout the intervention period, while caffeine is administered acutely prior to the test sessions; matching placebo capsules are used to maintain blinding across all groups.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
96 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07458594
Sponsor's protocol ID
2025602H
Acronym
CCRP-AD
Status last verified
Mar 2026
First submitted
4 Mar 2026
Last updated
9 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to participant confidentiality and institutional data protectionpolicies.

Questions about this trial

What is this clinical trial studying?

A study testing Caffeine and Rhodiola rosea extract in people with Aerial Duel Performance in Soccer Players, run by Beijing Sport University at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Early takeoff impulse (Impulse₀-₂₀₀) (time frame: Baseline (Day 0) and Post-intervention (Day 30), measured under both non-fatigued and fatigued conditions.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in